US 11384153
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11384153 (Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K40/11